| Home | E-Submission | Sitemap | Editorial Office |  
top_img
Clinical and Molecular Hepatology Search > Browse Articles > Search



Serum Wisteria floribunda agglutinin-positive human Mac-2 binding protein level predicts recurrence of hepatitis B virus-related hepatocellular carcinoma after curative resection
Hye Soo Kim, Seung Up Kim, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Young Nyun Park, Dai Hoon Han, Kyung Sik Kim, Jin Sub Choi, Gi Hong Choi, Hyon-Suk Kim
Clin Mol Hepatol.2020;26(1):33-44.   Published online June 27, 2019     
DOI: https://doi.org/10.3350/cmh.2018.0073
                              Supplementary      
Risk assessment of hepatocellular carcinoma development for indeterminate hepatic nodules in patients with chronic hepatitis B
Haneulsaem Shin, Yeon Woo Jung, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Yeun-Yoon Kim, Jin-Young Choi, Seung Up Kim
Clin Mol Hepatol.2019;25(4):390-399.   Published online May 31, 2019     
DOI: https://doi.org/10.3350/cmh.2018.0103
                              Supplementary      
Appropriate treatment modality for solitary small hepatocellular carcinoma: Radiofrequency ablation vs. resection vs. transplantation?
Keun Soo Ahn, Koo Jeong Kang
Clin Mol Hepatol.2019;25(4):354-359.   Published online April 22, 2019     
DOI: https://doi.org/10.3350/cmh.2018.0096
                              
Ultraselective conventional transarterial chemoembolization: When and how?
Shiro Miyayama
Clin Mol Hepatol.2019;25(4):344-353.   Published online April 26, 2019     
DOI: https://doi.org/10.3350/cmh.2019.0016
                                 Cited By 2
Detect or not to detect very early stage hepatocellular carcinoma? The western perspective
Ju Dong Yang
Clin Mol Hepatol.2019;25(4):335-343.   Published online March 29, 2019     
DOI: https://doi.org/10.3350/cmh.2019.0010
                                 Cited By 1
Underlying liver disease and advanced stage liver cancer are associated with elevated neutrophil-lymphocyte ratio
Linda Wong, Kliment Bozhilov, Brenda Hernandez, Sandi Kwee, Owen Chan, Luke Ellis, Loic LeMarchand
Clin Mol Hepatol.2019;25(3):305-316.   Published online April 19, 2019     
DOI: https://doi.org/10.3350/cmh.2019.0004
                              
Hepatocellular carcinoma surveillance in the 21st century: Saving lives or causing harm?
Ibrahim A. Hanouneh, Naim Alkhouri, Amit G. Singal
Clin Mol Hepatol.2019;25(3):264-269.   Published online March 4, 2019     
DOI: https://doi.org/10.3350/cmh.2019.1001
                                 Cited By 2
Comparison of international guidelines for noninvasive diagnosis of hepatocellular carcinoma: 2018 update
Tae-Hyung Kim, So Yeon Kim, An Tang, Jeong Min Lee
Clin Mol Hepatol.2019;25(3):245-263.   Published online February 14, 2019     
DOI: https://doi.org/10.3350/cmh.2018.0090
                                 Cited By 2
Development and surveillance of hepatocellular carcinoma in patients with sustained virologic response after antiviral therapy for chronic hepatitis C
Seong Kyun Na, Byung-Cheol Song
Clin Mol Hepatol.2019;25(3):234-244.   Published online January 21, 2019     
DOI: https://doi.org/10.3350/cmh.2018.0108
                                 Cited By 1
Gadoxetic acid-enhanced magnetic resonance imaging: Hepatocellular carcinoma and mimickers
Yeun-Yoon Kim, Mi-Suk Park, Khalid Suliman Aljoqiman, Jin-Young Choi, Myeong-Jin Kim
Clin Mol Hepatol.2019;25(3):223-233.   Published online January 21, 2019     
DOI: https://doi.org/10.3350/cmh.2018.0107
                                 Cited By 1
Unmet need in chronic hepatitis B management
Lilian Yan Liang, Grace Lai-Hung Wong
Clin Mol Hepatol.2019;25(2):172-180.   Published online February 12, 2019     
DOI: https://doi.org/10.3350/cmh.2018.0106
                                 Cited By 3
Direct-acting antivirals response in hepatocellular carcinoma: Does the presence of hepatocellular carcinoma matter?
Chung-Feng Huang, Ming-Lung Yu
Clin Mol Hepatol.2019;25(2):168-171.   Published online February 11, 2019     
DOI: https://doi.org/10.3350/cmh.2018.1014
                              
Safety margin of embolized area can reduce local recurrence of hepatocellular carcinoma after superselective transarterial chemoembolization
Kittipitch Bannangkoon, Keerati Hongsakul, Teeravut Tubtawee, Teerha Piratvisuth
Clin Mol Hepatol.2019;25(1):74-85.   Published online February 28, 2019     
DOI: https://doi.org/10.3350/cmh.2018.0072
                              
Radiomics and radiogenomics of primary liver cancers
Woo Kyoung Jeong, Neema Jamshidi, Ely Richard Felker, Steven Satish Raman, David Shinkuo Lu
Clin Mol Hepatol.2019;25(1):21-29.   Published online November 16, 2018     
DOI: https://doi.org/10.3350/cmh.2018.1007
                                 Cited By 8
Complete cure of advanced hepatocellular carcinoma with right adrenal gland metastasis and portal vein thrombosis by multiple applications of an interdisciplinary therapy: case report with 8-year follow up
Hojung Jung, Byung Ik Kim, Yong Kyun Cho, Woo Kyu Jeon, Hong Joo Kim, Hyun Pyo Hong
Clin Mol Hepatol.2018;24(4):424-429.   Published online November 14, 2017     
DOI: https://doi.org/10.3350/cmh.2017.0032
                              
Severe acute alcoholic hepatitis and liver transplant: A never-ending mournful story
Aiman Obed, Abdalla Bashir, Steffen Stern, Anwar Jarrad
Clin Mol Hepatol.2018;24(4):358-366.   Published online October 24, 2018     
DOI: https://doi.org/10.3350/cmh.2018.0044
                              
Comparison of surgical resection versus transarterial chemoembolization with additional radiation therapy in patients with hepatocellular carcinoma with portal vein invasion
Danbi Lee, Han Chu Lee, Jihyun An, Ju Hyun Shim, Kang Mo Kim, Young-Suk Lim, Young-Hwa Chung, Yung Sang Lee
Clin Mol Hepatol.2018;24(2):144-150.   Published online January 16, 2018     
DOI: https://doi.org/10.3350/cmh.2017.0041
                                 Cited By 3
Comparison of surgical resection versus transarterial chemoembolization with additional radiation therapy in patients with hepatocellular carcinoma with portal vein invasion
Jin Wook Chung
Clin Mol Hepatol.2018;24(2):135-136.   Published online February 22, 2018     
DOI: https://doi.org/10.3350/cmh.2018.1001
                              
Strategic application of radiotherapy for hepatocellular carcinoma
Seo Hee Choi, Jinsil Seong
Clin Mol Hepatol.2018;24(2):114-134.   Published online February 14, 2018     
DOI: https://doi.org/10.3350/cmh.2017.0073
                                 Cited By 8
Management of chronic hepatitis B patients in immunetolerant phase: what latest guidelines recommend
Grace Lai-Hung Wong
Clin Mol Hepatol.2018;24(2):108-113.   Published online January 22, 2018     
DOI: https://doi.org/10.3350/cmh.2017.0068
                                 Cited By 9
Epidemiology of liver cancer in South Korea
Bo Hyun Kim, Joong-Won Park
Clin Mol Hepatol.2018;24(1):1-9.   Published online December 18, 2017     
DOI: https://doi.org/10.3350/cmh.2017.0112
                                 Cited By 31
Complete response of advanced hepatocellular carcinoma to sorafenib : another case and a comprehensive review
Tae Suk Kim, Ji Hoon Kim, Baek hui Kim, Young-Sun Lee, Yang Jae Yoo, Seong Hee Kang, Sang-June Suh, Young Kul Jung, Yeon Seok Seo, Hyung Joon Yim, Jong Eun Yeon, Kwan Soo Byun
Clin Mol Hepatol.2017;23(4):340-346.   Published online June 20, 2017     
DOI: https://doi.org/10.3350/cmh.2016.0070
                                 Cited By 4
Treatment options after sorafenib failure in patients with hepatocellular carcinoma
Imane El Dika, Ghassan K. Abou-Alfa
Clin Mol Hepatol.2017;23(4):273-279.   Published online November 20, 2017     
DOI: https://doi.org/10.3350/cmh.2017.0108
                                 Cited By 8
Recent advances in transarterial embolotherapies in the treatment of hepatocellular carcinoma
Edward Wolfgang Lee, Sarah Khan
Clin Mol Hepatol.2017;23(4):265-272.   Published online November 8, 2017     
DOI: https://doi.org/10.3350/cmh.2017.0111
                                 Cited By 12
Surveillance of hepatocellular carcinoma: is only ultrasound enough?
Woo Kyoung Jeong
Clin Mol Hepatol.2017;23(3):222-223.   Published online September 19, 2017     
DOI: https://doi.org/10.3350/cmh.2017.0046
                                 Cited By 1
Risk score model for the development of hepatocellular carcinoma in treatment-naïve patients receiving oral antiviral treatment for chronic hepatitis B
Won Sohn, Ju-Yeon Cho, Ji Hoon Kim, Jung Il Lee, Hyung Joon Kim, Min-Ah Woo, Sin-Ho Jung, Yong-Han Paik
Clin Mol Hepatol.2017;23(2):170-178.   Published online May 16, 2017     
DOI: https://doi.org/10.3350/cmh.2016.0086
                              Supplementary         Cited By 7
Clinical features and outcomes of patients with hepatocellular carcinoma complicated with bile duct invasion
Jihyun An, Kwang Sun Lee, Kang Mo Kim, Do Hyun Park, Sang Soo Lee, Danbi Lee, Ju Hyun Shim, Young-Suk Lim, Han Chu Lee, Young-Hwa Chung, Yung Sang Lee
Clin Mol Hepatol.2017;23(2):160-169.   Published online May 16, 2017     
DOI: https://doi.org/10.3350/cmh.2016.0088
                                 Cited By 3
Meta-analysis of the correlation between the rs17401966 polymorphism in kinesin family member 1B and susceptibility to hepatitis B virus related hepatocellular carcinoma
Mingkuan Su, Jianfeng Guo, Jiancheng Huang
Clin Mol Hepatol.2017;23(2):138-146.   Published online April 21, 2017     
DOI: https://doi.org/10.3350/cmh.2016.0083
                                 Cited By 2
Can metronomic chemotherapy be an alternative to sorafenib in advanced hepatocellular carcinoma?
Do Young Kim
Clin Mol Hepatol.2017;23(2):123-124.   Published online June 23, 2017     
DOI: https://doi.org/10.3350/cmh.2017.0107
                              
Radioembolization for the treatment of hepatocellular carcinoma
Hyo-Cheol Kim
Clin Mol Hepatol.2017;23(2):109-114.   Published online May 10, 2017     
DOI: https://doi.org/10.3350/cmh.2017.0004
                                 Cited By 13
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 |
E-Submission
Email Alert
Author's Index
EndNote Style file download
The Korean Association for the Study of the Liver
The Liver Week 2019
SCImago Journal & Country Rank
PubMed Central
PubMed
Scopus
KoreaMed
KoMCI
ScienceCentral
DOAJ
GoogleScholar
Similarity Check
Crossref Cited-by Linking
CrossMark
Funder Registry
ORCID
MeSH on Demand
COPE
Editorial Office
The Korean Association for the Study of the Liver
Room A1210, 53 Mapo-daero(MapoTrapalace, Dowha-dong), Mapo-gu, Seoul, 04158, Korea
TEL: +82-2-703-0051   FAX: +82-2-703-0071    E-mail: kasl@kams.or.kr
About |  Browse Articles |  Current Issue |  For Authors and Reviewers
Copyright © The Korean Association for the Study of the Liver. All rights reserved.         
COUNTER
TODAY : 472
TOTAL : 292904